Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis - Kuwana, M; Blair, C; Takahashi, T (Ann Rheum Dis, 2020)
et al.